Recurrent Autoimmune Liver Disease and Its Impact on Clinical Practice
暂无分享,去创建一个
[1] F. Nevens,et al. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival. , 2019, Gastroenterology.
[2] A. Montano‐Loza,et al. Recurrent and De Novo Autoimmune Hepatitis , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] P. Trivedi,et al. The impact of ileal pouch‐anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis , 2018, Alimentary pharmacology & therapeutics.
[4] M. Bottai,et al. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study , 2018, Scandinavian journal of gastroenterology.
[5] P. Trivedi,et al. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis. , 2017, Journal of hepatology.
[6] J. Neuberger,et al. Twenty‐Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] Satish K. Kedia,et al. Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid , 2017, Transplantation direct.
[8] A. Montano‐Loza,et al. Systematic review: recurrent autoimmune liver diseases after liver transplantation , 2017, Alimentary pharmacology & therapeutics.
[9] M. Manns,et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[10] J. Neuberger,et al. Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] D. Maucort-Boulch,et al. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence. , 2015, Journal of hepatology.
[12] A. Burroughs,et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. , 2015, Journal of hepatology.
[13] R. Wiesner,et al. Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease , 2013, Transplantation.
[14] N. Heaton,et al. The impact of inflammatory bowel disease post‐liver transplantation for primary sclerosing cholangitis , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[15] A. Burroughs,et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). , 2012, Journal of Hepatology.
[16] A. Montano‐Loza,et al. Cyclosporine A Protects Against Primary Biliary Cirrhosis Recurrence After Liver Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] P. Neuhaus,et al. Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] A. Montano‐Loza,et al. Risk factors for recurrence of autoimmune hepatitis after liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.